Dan Liao

3.2k total citations · 1 hit paper
35 papers, 2.2k citations indexed

About

Dan Liao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dan Liao has authored 35 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dan Liao's work include Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (6 papers) and RNA modifications and cancer (6 papers). Dan Liao is often cited by papers focused on Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (6 papers) and RNA modifications and cancer (6 papers). Dan Liao collaborates with scholars based in China, United States and Singapore. Dan Liao's co-authors include Tiebang Kang, Ruhua Zhang, Li Zhong, Xin Wang, Yue Xing, Man‐Li Luo, Fengxi Su, Di Huang, Linbin Yang and Fei Chen and has published in prestigious journals such as Cell, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Dan Liao

34 papers receiving 2.2k citations

Hit Papers

CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer ... 2018 2026 2020 2023 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Liao China 18 1.4k 833 753 374 262 35 2.2k
Stéphanie Dauvillier France 14 1.4k 1.0× 942 1.1× 1.0k 1.4× 366 1.0× 182 0.7× 20 2.5k
Yanqing Gong United States 19 771 0.5× 480 0.6× 473 0.6× 484 1.3× 183 0.7× 35 1.7k
Thomas Bertero France 23 1.4k 1.0× 449 0.5× 1.1k 1.5× 227 0.6× 488 1.9× 35 2.4k
Kiera Rycaj United States 22 1.4k 1.0× 770 0.9× 572 0.8× 288 0.8× 433 1.7× 29 2.2k
François Lamoureux France 31 1.6k 1.1× 830 1.0× 567 0.8× 216 0.6× 717 2.7× 73 2.5k
Alicia S. Chung United States 11 1.4k 1.0× 798 1.0× 517 0.7× 521 1.4× 153 0.6× 16 2.3k
Maria Rosa Bani Italy 28 1.6k 1.1× 789 0.9× 509 0.7× 384 1.0× 116 0.4× 62 2.4k
Jianfei Huang China 31 1.6k 1.1× 761 0.9× 866 1.2× 324 0.9× 313 1.2× 96 2.5k
Hao Yuan China 22 1.4k 1.0× 959 1.2× 909 1.2× 418 1.1× 172 0.7× 47 2.2k
Mohamed H. Abdel‐Rahman United States 24 943 0.7× 637 0.8× 266 0.4× 406 1.1× 324 1.2× 81 2.4k

Countries citing papers authored by Dan Liao

Since Specialization
Citations

This map shows the geographic impact of Dan Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Liao more than expected).

Fields of papers citing papers by Dan Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Liao. The network helps show where Dan Liao may publish in the future.

Co-authorship network of co-authors of Dan Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Liao. A scholar is included among the top collaborators of Dan Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Liao. Dan Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Ying, Denghui Wei, Li Zhong, et al.. (2025). Extracellular vesicles in cancer progression: mechanisms and significance. Science China Life Sciences.
2.
Huang, Jintao, Zhiguang Zhang, Ruhua Zhang, et al.. (2024). Up-regulation of RAN by MYBL2 maintains osteosarcoma cancer stem-like cells population during heterogeneous tumor generation. Cancer Letters. 586. 216708–216708. 8 indexed citations
3.
Liao, Dan, et al.. (2023). Unveiling the potential role of natriuretic peptide receptor a isoforms in fine-tuning the cGMP production and tissue-specific function. Scientific Reports. 13(1). 20439–20439. 1 indexed citations
4.
Liu, Wenqiang, et al.. (2023). CRISPR screen identifies GATAD1 as a synthetic lethal target with CDK4/6 inhibitors in estrogen receptor-positive breast cancer. Medical Oncology. 40(9). 267–267. 2 indexed citations
5.
Zhong, Li, Dan Liao, Jingjing Li, et al.. (2021). Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes. Signal Transduction and Targeted Therapy. 6(1). 59–59. 73 indexed citations
6.
Wang, Boqing, Jianjun Tang, Dan Liao, et al.. (2021). Correction to: Chromobox Homolog 4 is Correlated with Prognosis and Tumor Cell Growth in Hepatocellular Carcinoma. Annals of Surgical Oncology. 28(S3). 885–886. 2 indexed citations
7.
Liao, Dan, Li Zhong, Junqiang Yin, et al.. (2020). Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma. Nature Cell Biology. 22(7). 868–881. 47 indexed citations
8.
Liao, Dan, Li Zhong, Junqiang Yin, et al.. (2020). Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma. Nature Cell Biology. 22(7). 907–907. 1 indexed citations
9.
Wang, Xin, Ge Qin, Xiaoting Liang, et al.. (2020). Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma. Nature Communications. 11(1). 1141–1141. 110 indexed citations
10.
Liang, Xiaoting, Xin Wang, Yaohui He, et al.. (2020). Acetylation dependent functions of Rab22a-NeoF1 Fusion Protein in Osteosarcoma. Theranostics. 10(17). 7747–7757. 12 indexed citations
11.
Wang, Shang, Li Zhong, Yin Li, et al.. (2019). Up-regulation of PCOLCE by TWIST1 promotes metastasis in Osteosarcoma. Theranostics. 9(15). 4342–4353. 56 indexed citations
12.
Liao, Dan, et al.. (2019). Upregulation of Yy1 Suppresses Dilated Cardiomyopathy caused by Ttn insufficiency. Scientific Reports. 9(1). 16330–16330. 6 indexed citations
13.
Li, Xinchun, Li Zhong, Zhuo Wang, et al.. (2018). Phosphorylation of IRS4 by CK1γ2 promotes its degradation by CHIP through the ubiquitin/lysosome pathway. Theranostics. 8(13). 3643–3653. 17 indexed citations
14.
Liao, Dan, et al.. (2018). Inhibition of 5-lipoxygenase represses neutrophils activation and activates apoptosis in pancreatic tissues during acute necrotizing pancreatitis. Biochemical and Biophysical Research Communications. 498(1). 79–85. 5 indexed citations
15.
Su, Shicheng, Jianing Chen, Herui Yao, et al.. (2018). CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 172(4). 841–856.e16. 921 indexed citations breakdown →
16.
Wang, Gang, Jianjun Tang, Ruhua Zhang, et al.. (2017). CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma. Theranostics. 7(14). 3478–3488. 40 indexed citations
17.
Wang, Xin, Liping Li, Yuanzhong Wu, et al.. (2016). CBX4 Suppresses Metastasis via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma. Cancer Research. 76(24). 7277–7289. 69 indexed citations
18.
Liao, Dan, Li Zhong, Ru-Hua Zhang, et al.. (2015). Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway. Clinical Cancer Research. 21(23). 5349–5359. 101 indexed citations
19.
Liao, Dan, et al.. (2014). Chemerin C9 peptide induces receptor internalization through a clathrin-independent pathway. Acta Pharmacologica Sinica. 35(5). 653–663. 24 indexed citations
20.
Liao, Dan, et al.. (2008). Cloning and characterization of Rv0621 gene related to surfactant stress tolerance in Mycobacterium tuberculosis. Molecular Biology Reports. 36(7). 1811–1817. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026